ADVERTISEMENT
Reflecting on Advancements in the Treatment of HER2-Positive Breast Cancer
12/11/2019
Sherene Loi, MD, PhD, Consultant Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne, Australia, reflects on advances made in the treatment landscape for HER2-positive breast cancer in the past 2 decades.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement